Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Int J Gynaecol Obstet. 2020 Dec 23;152(2):208–214. doi: 10.1002/ijgo.13464

TABLE 3.

Contraceptive use and preferencesa

Contraceptive methodb Before visit Future wishes P valuec
Baseline (n = 141) 0.16
 Very effective contraception 7 (5.0) 11 (7.8)
 Effective contraception 11 (7.8) 18 (12.7)
 Less effective contraception 100 (70.9) 92 (65.2)
 Not effective contraception 20 (14.2) 19 (13.5)
 Unknown 3 (2.1) 1 (0.7)
Post intervention (n = 107)
 Very effective contraception 6 (5.6) 32 (30.0) <0.001
 Effective contraception 11 (10.3) 14 (13.1)
 Less effective contraception 73 (68.2) 46 (43.0)
 Not effective contraception 13 (12.2) 11 (10.3)
 Unknown 4 (3.7) 4 (3.7)
a

Data are given as number (percentage).

b

Very effective contraception included the copper and hormonal intrauterine contraceptive device, the levonorgestrel and etonogestrel implants and tubal ligation. Effective contraception included the 3-monthly injectable (DMPA, Depo Provera) and oral contraceptive pill (both combined and progesterone only). Less effective contraception included the male and female condom. Not effective contraception included no method and abstinence. No patients in either survey indicated using natural methods, withdrawal, the patch or the ring.

c

P relates to within-participant comparison.